The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

被引：0
|
作者：
Wong, Yu Jun [1 ]
Manejero, Fria May Gloriba [1 ]
Lim, Kim Wei [1 ]
Chong, Sin Yoong [1 ]
Mai, Linn War [1 ]
Kumar, Rahul [1 ]
Teo, Eng Kiong [1 ]
Tan, Jessica [1 ]
Hsiang, John Chen [2 ]
Thurairajah, Prem Harichander [1 ]
机构：
[1] Changi Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
[2] Sengkang Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU354
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 3 HEPATITIS C VIRUS-INFECTED PATIENTS: A REAL-WORLD STUDY OF CHINA AND SAFETY OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 3 HEPATITIS C VIRUS-INFECTED PATIENTS: A REAL-WORLD STUDY OF CHINA
    Yue, Wei
    Liu, Li
    Xiao, An
    Du, Yingrong
    Gao, Jianpeng
    Liu, Min
    Wang, Yilan
    Che, Meng
    Guo, Jiaxiang
    Li, Junyi
    Geng, Jiawei
    HEPATOLOGY, 2021, 74 : 589A - 589A
  • [2] Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients
    Perdita Wietzke-Braun
    Volker Meier
    Katrin Neubauer-Saile
    Sabine Mihm
    Giuliano Ramadori
    World Journal of Gastroenterology, 2005, (39) : 6188 - 6192
  • [3] Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients
    Wietzke-Braun, Perdita
    Meier, Volker
    Neubauer-Saile, Katrin
    Mihm, Sabine
    Ramadori, Giuliano
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (39) : 6188 - 6192
  • [4] Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients
    Morio, Kei
    Imamura, Michio
    Kawakami, Yoshiiku
    Morio, Reona
    Kobayashi, Tomoki
    Yokoyama, Satoe
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Makokha, Grace Naswa
    Hayes, C. Nelson
    Aikata, Hiroshi
    Miki, Daiki
    Ochi, Hidenori
    Honda, Yoji
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 645 - 650
  • [5] Optimising the impact of direct-acting antiviral treatment in Hepatitis C: Lessons from a universal access, real-world cohort
    Thwaites, Phoebe A.
    Braund, Alicia
    Legg, Amy
    Beckman, Karen
    Mina, Joanne C.
    McIntyre, Deborah
    Cullen, Olivia
    Fenech, Mary
    Redden, Mark
    van Rensburg, Anzel Jansen
    Zhou, Xinyi Tom
    Hallam, Andrew
    Rahman, Tony
    Wood, Marnie
    Leggett, Barbara
    Skoien, Richard
    HEPATOLOGY, 2017, 66 : 841A - 841A
  • [6] Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4
    Zarebska-Michaluk, Dorota
    Jaroszewicz, Jerzy
    Buczynska, Iwona
    Simon, Krzysztof
    Lorenc, Beata
    Tudrujek-Zdunek, Magdalena
    Tomasiewicz, Krzysztof
    Sitko, Marek
    Garlicki, Aleksander
    Janczewska, Ewa
    Dybowska, Dorota
    Halota, Waldemar
    Pawlowska, Malgorzata
    Pabjan, Pawel
    Mazur, Wlodzimierz
    Czauz-Andrzejuk, Agnieszka
    Berak, Hanna
    Horban, Andrzej
    Socha, Lukasz
    Klapaczynski, Jakub
    Piekarska, Anna
    Blaszkowska, Maria
    Belica-Wdowik, Teresa
    Dobracka, Beata
    Tronina, Olga
    Deron, Zbigniew
    Bialkowska-Warzecha, Jolanta
    Laurans, Lukasz
    Flisiak, Robert
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (07) : 1238 - 1246
  • [7] The Impact of Cirrhosis in Genotype 3 Hepatitis C Treatment Outcome
    Cardoso, Helder
    Albuquerque, Andreia
    Moura, Marta Casal
    Marques, Margarida
    Horta e Vale, Ana
    Vilas-Boas, Filipe
    Araujo, Fernando
    Macedo, Guilherme
    GASTROENTEROLOGY, 2014, 146 (05) : S259 - S259
  • [8] Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
    Zoulim, Fabien
    Liang, T. Jake
    Gerbes, Alexander L.
    Aghemo, Alessio
    Deuffic-Burban, Sylvie
    Dusheiko, Geoffrey
    Fried, Michael W.
    Pol, Stanislas
    Rockstroh, Juergen Kurt
    Terrault, Norah A.
    Wiktor, Stefan
    GUT, 2015, 64 (11) : 1824 - 1833
  • [9] Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan
    Mizokami, Masashi
    Liu, Lauren J.
    Fujiyama, Naoto
    Littman, Marcus
    Yuan, Jason
    Sekiya, Tomoko
    Hedskog, Charlotte
    Ng, Leslie J.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) : 129 - 141
  • [10] Genotype-specific versus pangenotypic regimens in patients infected with hepatitis C virus genotype 1b in real-world settings
    Pabjan, Pawel
    Brzdek, Michal
    Chrapek, Magdalena
    Dziedzic, Kacper
    Stepie, Piotr M.
    Paluch, Katarzyna
    Garbat, Anna
    Bloniarczyk, Piotr
    Reczko, Katarzyna
    Zarebska-Michaluk, Dorota
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (11):
12345